jlagasse

Author's posts

Physicians ask Senate Finance Committee to address kickbacks, other factors driving up drug costs

The AAPS recommended a number of specific solutions, including ending the safe harbor to the Medicare Anti-Kickback Statute.

What’s the lifetime cost of gender salary disparities? It adds up, Johns Hopkins says

Efforts to eliminate gender disparity have cut the gap in salaries that men and women earn at Johns Hopkins, but the differences make an impact.

Healthcare mergers and acquisitions had record year in 2018, up 14.4 percent

The volume of deals topped 2017, which was itself a banner year, but the value of deals has dipped during that time.

How artificial intelligence can be used to reduce costs and improve outcomes in total joint replacement surgery

Use of AI led to cost reductions including a 25 percent drop in hospital length of stay and 91 percent reduction in discharges to nursing facilities.

Orthopedic surgery spending increased 44 percent since 2010

Volume increase is the main cost driver, as the number of such procedures has sharply risen across nearly all ages under 65.

Most hospitals would likely benefit from third-party liability insurance coverage, says ERI

TPL reimbursements can recoup as much as 100 percent of charges levied, double commercial rates and more than triple governmental plan rates.

Disclosing drug prices won’t drive down costs, JAMA says

Even if its passed into law, proposed legislation to force frice disclosures is unlikely to create the kind of competition that affect prices.

Looking to slash hospital supply chain costs? Centralizing operations is one way to do it

By creating economies of scale with a full-service supply chain, University of Missouri Health Care was able to improve its bottom line.

Bundled payment programs in healthcare becoming more common despite lack of comprehensive IT solution

CMS’ renewed interest in mandatory bundled payments includes the possibility of additional participation for oncology and other providers.

More than half of consumers lack confidence in their ability to properly take new medications as directed

Spending for retail prescription drugs reached $333.4 billion in 2017, and those rising costs represent 10 percent of overall healthcare spend.